The triglyceride paradox in people of African descent

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 2, 2012, Pages 77-82

  Yu, Sophia S K ^a   Castillo, Darleen C ^a   Courville, Amber B ^b   Sumner, Anne E ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AFRICA; AFRICAN DESCENT; DYSLIPIDEMIA; ETHNICITY; EUROPE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NORTH AMERICA; PRIORITY JOURNAL; REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; TRIGLYCERIDES;

EID: 84858813372     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0108     Document Type: Review

References (51)

1. Patel A, Barzi F, Jamrozik K, et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004;110:2678-2686.
2. Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007;115:450-458.
3. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
4. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: A population-based comparison. Diabetes Care 2006;29:151-153.
5. Kahn HS, Cheng YJ, Thompson TJ, et al. Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. Ann Intern Med 2009;150:741-751.
6. Lemieux I, Pascot A, Couillard C, et al. Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000;102:179-184.
7. McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-809.
8. Meigs JB, Williams K, Sullivan LM, et al. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care 2004;27:1417-1426.
9. St-Pierre J, Lemieux I, Perron P, et al. Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 2007; 99:369-373.
10. Tanko LB, Bagger YZ, Qin G, et al. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005;111:1883-1890.
11. Wilson PW, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study. Arch Intern Med 2007;167:1068-1074.
12. Godsland IF, Johnston DG, Chaturvedi N. Mechanisms of disease: Lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease. Nat Clin Pract Endocrinol Metab 2007;3:530-538.
13. Sumner AE, Zhou J, Doumatey A, et al. Low HDLcholesterol with normal triglyceride levels is the most common lipid pattern in West Africans and African Americans with metabolic syndrome: Implications for cardiovascular disease prevention. CVD Prev Control 2010;5:75-80.
14. Tillin T, Forouhi NG, McKeigue PM, et al. The role of diabetes and components of the metabolic syndrome in stroke and coronary heart disease mortality in U.K. white and African-Caribbean populations. Diabetes Care 2006;29:2127-2129.
15. Giannini E, Testa R. The metabolic syndrome: All criteria are equal, but some criteria are more equal than others. Arch Intern Med 2003;163:2787-2788; author reply 2788.
16. Osei K. Metabolic syndrome in blacks: Are the criteria right? Curr Diab Rep 2010;10:199-208.
17. Sumner AE. "Half the dsylipidemia of insulin resistance" is the dsylipidemia of insulin-resistant Blacks. Ethn Dis 2009;19: 462-465.
18. Sumner AE, Cowie CC. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis 2008;196:696-703.
19. Pischon T, Hu FB, Rexrode KM, et al. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 2008;197:392-399.
20. Adiels M, Olofsson SO, Taskinen MR, et al. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:1225-1236.
21. Choi SH, Ginsberg HN. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab 2011;22:353-363.
22. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2011;123:2292-2333.
23. Barter PJ, Brewer HB Jr, Chapman MJ, et al. Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23: 160-167.
24. Chait A, Brazg RL, Tribble DL, et al. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 1993;94:350-356.
25. Skeggs JW, Morton RE. LDL and HDL enriched in triglyceride promote abnormal cholesterol transport. J Lipid Res 2002; 43:1264-1274.
26. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 2009:1-7.
27. Park YW, Zhu S, Palaniappan L, et al. Themetabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
28. Chaturvedi N, McKeigue PM, Marmot MG. Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans. Diabetologia 1994;37:765-772.
29. Chow CC, Periwal V, Csako G, et al. Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women. J Clin Endocrinol Metab 2011;96:2456-2463.
30. Despres JP, Couillard C, Gagnon J, et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: The Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000;20:1932-1938.
31. Sternfeld B, Sidney S, Jacobs DR Jr, et al. Seven-year changes in physical fitness, physical activity, and lipid profile in the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1999;9:25-33.
32. Freedman DS, Bowman BA, Otvos JD, et al. Differences in the relation of obesity to serum triacylglycerol and VLDL subclass concentrations between black and white children: The Bogalusa Heart Study. Am J Clin Nutr 2002;75:827-833.
33. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:e21-e181.
34. Goedecke JH, Utzschneider K, Faulenbach MV, et al. Ethnic differences in serum lipoproteins and their determinants in South African women. Metabolism 2010;59:1341-1350.
35. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
36. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-636.
37. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
38. Ukegbu UJ, Castillo DC, Knight MG, et al. Metabolic syndrome does not detect metabolic risk in African men living in the U.S. Diabetes Care 2011;34:2297-2299.
39. Arsenault BJ, Lemieux I, Despres JP, et al. The hypertriglyceridemic- waist phenotype and the risk of coronary artery disease: Results from the EPIC-Norfolk prospective population study. CMAJ 2010;182:1427-1432.
40. Sumner AE, Finley KB, Genovese DJ, et al. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005;165:1395-1400.
41. Li C, Ford ES, Meng YX, et al. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 2008;7:4.
42. Taylor HA, Jr., Wilson JG, Jones DW, et al. Toward resolution of cardiovascular health disparities in African Americans: Design and methods of the Jackson Heart Study. Ethn Dis 2005;15(4 Suppl 6):S6-4-17.
43. Sumner AE, Harman JL, Buxbaum SG, et al. The triglyceride/ high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: An analysis of Jackson Heart Study. Metab Syndr Relat Disord 2010;8: 511-514.
44. Knight MG, Goedecke JH, Ricks M, et al. The TG/HDL-C ratio does not predict insulin resistance in overweight women of African descent: A study of South African, African American and West African women. Ethn Dis (in press).
45. Florez H, Mendez A, Casanova-Romero P, et al. Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis 2006;188: 134-141.
46. Maheux P, Azhar S, Kern PA, et al. Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 1997;40: 850-858.
47. Sumner AE, Vega GL, Genovese DJ, et al. Normal triglyceride levels despite insulin resistance in African Americans: Role of lipoprotein lipase. Metabolism 2005;54:902-909.
48. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-748.
49. Osei K, Schuster DP. Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med 1994;11:755-762.
50. Guerrero R, Vega GL, Grundy SM, et al. Ethnic differences in hepatic steatosis: An insulin resistance paradox? Hepatology 2009;49:791-801.
51. Gastaldelli A, Casolaro A, Ciociaro D, et al. Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients. Am J Physiol Endocrinol Metab 2009;297:E225-E230.